| Factor Information | |
|---|---|
| Data ID | 4176 |
| Factor | percent of requiring ECMO(extracorporeal membrane oxygenation) |
| Description | Infants with SVP were more likely to require ECMO than TGA. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To determine the spectrum of brain injury and compare brain volumes between pre- and postoperative brain MRI in the infants receiving extracorporeal membrane oxygenation compared with those who did not require ECMO. |
| p Value | <0.001 |
| Conclusion | Infants with SVP were more likely to require ECMO than TGA. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 750 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | HLHS/SV/TGA, DORV/TGA, IVS/TGA, VSD |
| Reference | |
|---|---|
| PMID | 32195905 |
| Year | 2020 |
| Title | Decreased Brain Volumes and Infants With Congenital Heart Disease Undergoing Venoarterial Extracorporeal Membrane Oxygenation |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | patients | |
| Region | Toronto, Canada | |
| Method | Prospective and single-centered study; Fisher exact test | |
| Race | North American | |
| Disease History | N/A | |
| Treatment History | ECMO(extracorporeal membrane oxygenation) | |
| Group | SVP,single ventricle physiology(Treatment) | TGA(Control) |
| Number | 9(total:77) | 19(total:32) |
| Age | gestational age:39.0 (38.2–39.4)weeks | gestational age:39.1 (38.6–40.0)weeks |
| Gender (Male: Female) | 16:12 | 57:34 |
| Marker Level | 0.594 | 0.1169 |
